What is a stock summary page? Click here for an overview.
Business Description
Bachem Holding AG
ISIN : CH1176493729
Compare
Compare
Traded in other countries / regions
BANB.SwitzerlandBANBz.UKBCHMF.USABHM0.GermanyBANB.Mexico IPO Date
2013-05-10Description
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 328.27 | |||||
| Equity-to-Asset | 0.72 | |||||
| Interest Coverage | 2660.96 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 6 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.4 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 1.4 | |||||
| 3-Year FCF Growth Rate | -89.3 | |||||
| 3-Year Book Growth Rate | 6.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 19.31 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 23.88 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36 | |||||
| 9-Day RSI | 38.89 | |||||
| 14-Day RSI | 40.13 | |||||
| 3-1 Month Momentum % | -0.43 | |||||
| 6-1 Month Momentum % | -16.71 | |||||
| 12-1 Month Momentum % | -31.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.93 | |||||
| Quick Ratio | 1.33 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 344.01 | |||||
| Days Sales Outstanding | 111.08 | |||||
| Days Payable | 41.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.49 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | 7.2 | |||||
| Forward Dividend Yield % | 1.58 | |||||
| 5-Year Yield-on-Cost % | 2.17 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 1.52 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.16 | |||||
| Operating Margin % | 21.98 | |||||
| Net Margin % | 19.87 | |||||
| FCF Margin % | -22.85 | |||||
| ROE % | 8.98 | |||||
| ROA % | 6.77 | |||||
| ROIC % | 7.75 | |||||
| 3-Year ROIIC % | 0.63 | |||||
| ROC (Joel Greenblatt) % | 10.36 | |||||
| ROCE % | 8.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.2 | |||||
| Forward PE Ratio | 30.84 | |||||
| PE Ratio without NRI | 31.77 | |||||
| Shiller PE Ratio | 49.69 | |||||
| PEG Ratio | 2.69 | |||||
| PS Ratio | 6.58 | |||||
| PB Ratio | 2.87 | |||||
| Price-to-Tangible-Book | 2.93 | |||||
| Price-to-Operating-Cash-Flow | 27.29 | |||||
| EV-to-EBIT | 29.12 | |||||
| EV-to-Forward-EBIT | 26.61 | |||||
| EV-to-EBITDA | 22.06 | |||||
| EV-to-Forward-EBITDA | 19.41 | |||||
| EV-to-Revenue | 6.5 | |||||
| EV-to-Forward-Revenue | 5.74 | |||||
| EV-to-FCF | -28.37 | |||||
| Price-to-GF-Value | 0.62 | |||||
| Price-to-Projected-FCF | 5.18 | |||||
| Price-to-DCF (Earnings Based) | 0.87 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.72 | |||||
| Price-to-Graham-Number | 2.05 | |||||
| Price-to-Net-Current-Asset-Value | 13.81 | |||||
| Earnings Yield (Greenblatt) % | 3.44 | |||||
| FCF Yield % | -3.43 | |||||
| Forward Rate of Return (Yacktman) % | 11.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bachem Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 605.259 | ||
| EPS (TTM) (CHF) | 1.6 | ||
| Beta | 0.1 | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 36.85 | ||
| 14-Day RSI | 40.13 | ||
| 14-Day ATR (CHF) | 1.552865 | ||
| 20-Day SMA (CHF) | 55.34875 | ||
| 12-1 Month Momentum % | -31.38 | ||
| 52-Week Range (CHF) | 52.4 - 91.6 | ||
| Shares Outstanding (Mil) | 74.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bachem Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bachem Holding AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bachem Holding AG Frequently Asked Questions
What is Bachem Holding AG(CHIX:BANBz)'s stock price today?
The current price of CHIX:BANBz is CHF53.85. The 52 week high of CHIX:BANBz is CHF91.60 and 52 week low is CHF52.40.
When is next earnings date of Bachem Holding AG(CHIX:BANBz)?
The next earnings date of Bachem Holding AG(CHIX:BANBz) is .
Does Bachem Holding AG(CHIX:BANBz) pay dividends? If so, how much?
The Dividend Yield %  of Bachem Holding AG(CHIX:BANBz) is 1.49% (As of Today), Highest Dividend Payout Ratio of Bachem Holding AG(CHIX:BANBz) was 0.85. The lowest was 0.41. And the median was 0.62. The  Forward Dividend Yield % of Bachem Holding AG(CHIX:BANBz) is 1.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers